Finasteride is a Food and Drug Administration (FDA) approved pill used to treat a noncancerous enlargement of the prostate that can block the flow of urine.
A 10-year study of more than 18,000 men was completed by the National Cancer Institute. The goal was to see whether low-dose finasteride cut the rate of prostate cancer in subjects. About half the guys in the study got finasteride (5 milligram daily dose); the other half got a placebo (sugar pill). At the end of the study, the results were clear: 18% of men in the finasteride group developed prostate cancer vs. 24% of men in the placebo group. That means the guys taking finasteride had an overall rate of prostate cancer 25% less than the guys on placebo.
Finasteride is a Food and Drug Administration (FDA) approved pill
used to treat a noncancerous enlargement of the prostate that can
block the flow of urine. A 10-year study of more than 18,000 men
was completed by the National Cancer...
More